Canadian Pacific Kansas City Limited Common Shares vs IDEXX Laboratories, Inc. — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $83.86 (market cap $73.71B), while IDEXX Laboratories, Inc. trades at $512.76 (market cap $39.92B). The key difference: Canadian Pacific Kansas City Limited Common Shares is the larger of the two by market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.91% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| CP | IDXX | |
|---|---|---|
Market Cap | $73.71B | $39.92B |
Volume | 2,143,178 | 715,982 |
Sector | Industrials | Health |
52-Week High | $96.69 | $766.68 |
52-Week Low | $68.88 | $504.70 |
Enterprise Value | $91.14B | $40.82B |
Dividend Yield | 0.91% | — |
Typical Hold Time | — | 46 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IDEXX Laboratories (IDXX) trades at $513.14, down 0.44% with bearish technical signals despite strong fundamentals. The company demonstrates robust revenue growth, expanding from $3.4B in 2022 to $4.3B in 2025, with net income reaching $1.06B. Recent acquisitions like CoVetAI and diagnostic platform expansions highlight strategic growth initiatives. Technical indicators show oversold conditions with RSI at 26.58, while moving averages signal bearish momentum. Analyst consensus remains optimistic with a $665 price target representing 30% upside potential.
The outlook remains positive given strong earnings beats, expanding profit margins, and strategic acquisitions. However, risks include technical weakness, FX headwinds, and competitive pressures. With 56.5% analyst buy ratings and institutional accumulation, IDXX offers growth potential but requires monitoring of technical support levels near $492-$502 for entry opportunities.
Trailing returns across standard periods
Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.
Read more on CP →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →